Sven Mahner, MD, on Advanced Ovarian Cancer: Radical Upfront Surgery

Posted: Friday, June 6, 2025

Sven Mahner, MD, of University Hospital, Ludwig-Maximilians-Universität München, discusses findings from TRUST, an international open, randomized, controlled multicenter trial investigating overall survival after primary cytoreductive surgery vs neoadjuvant chemotherapy and subsequent interval cytoreductive surgery in patients with advanced ovarian, tubal, and peritoneal carcinoma (LBA5500).

---